Breaking News

Successful Sterile Inspection for Scottish CMO

Symbiosis has been re-inspected and approved for the ongoing production of IMPs for clinical trials

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Injectable manufacturing specialist Symbiosis Pharmaceutical Services has successfully completed a scheduled inspection from the UK Government Regulator, the Medicines and Healthcare products Regulatory Agency (MHRA). The contract manufacturing organization (CMO) received no critical or major observations. Symbiosis has been re-inspected and approved for the ongoing production of investigational medicinal products (IMPs) for clinical trials. In a further boost to support the growth and str...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters